2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Session 9 – Biotech Business Models and Financing Strategy

 

Session 9 – Biotech Business Models and Financing Strategy

Date: 23 July (Thursday) 15:40 – 17:10 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform


This session will call on the collective knowledge of an exciting lineup of industry veterans with global experience in building and financing biotech companies. From case studies encompassing Genentech, AstraZeneca, Innoforce, Seneca Biopharma and Lilly Asia Venture, learn what it takes for both early stage and mature biotech and pharma companies to grow and innovate through financing, licensing and M&A. 



Opening Remarks

 

Joseph Chou

Chairman and CEO
PricewaterhouseCoopers Taiwan​

 

Speakers

 

Joseph McCracken

Board Member and Consultant
 

Ji Li

Venture Partner
Lilly Asia Ventures​

   

Kenneth Carter

Head of Corporate Development
Innoforce

Shaun Grady

SVP Business Development Operations
AstraZeneca plc​